From Design & Development to quantitative solutions

The team has built out the foundational platform and technology to extract and leverage financial market data in real-time and improve financial investment decisions. Most of the solutions developed have been tested and traded since 2013 and the management company has utilized this technology to manage private investments.  

The Legacy and History behind G6

G6 Data Sciences was founded with the purpose to leverage a unique expertise of transforming complex data sets into actionable information and provide solutions across a number of industries.   After significant research and development G6 Data Sciences spun out two businesses over the years - G6 Capital Management to focus on the stock market data and Health Data Analytics Institute to focus on healthcare data and its varying applications.

Prior to G6 Data Sciences, Nassib Chamoun was the Founder, President and CEO of Aspect Medical Systems, which he led from startup to a $100M global, publicly-traded company. Aspect’s premier product, the Bispectral Index™ (BIS™) technology, for which Chamoun was the primary inventor, is the first clinically validated direct measure of the effects of anesthetics on the brain. BIS™ technology is available in a majority of hospitals in the US, Europe and Japan, has been used clinically in approximately 50 million patients and has been the subject of more than 3,500 published articles and abstracts. BIS™ technology has been proven to reduce the risk of awareness with recall during surgery, facilitate faster wake-ups with less recovery time and reduce anesthetic use. In 2009, Chamoun guided the acquisition of Aspect Medical by Covidien, a leading $12 billion global healthcare products company. From 2009 to 2010 he assisted the CEO of Covidien in the capacity of Vice President of Technology, Research and Clinical Development.

 While at Aspect Medical, Chamoun was also the inventor of RSI (or risk stratification indices), a broadly applicable and robust system for assessing hospital length of stay and mortality for groups of surgical patients based solely on administrative data. Over the years, he has published extensively on RSI in many academic-medical journals, including in collaboration with Cleveland Clinic and the Lown Institute. Chamoun presently serves as Chairman of the Board of the Lown Institute and is a member of the Northeastern University Corporation. He was a long-time Director of the Anesthesia Patient Safety Foundation.